GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (OTCPK:TCNNF) » Definitions » EPS (Diluted)

Trulieve Cannabis (Trulieve Cannabis) EPS (Diluted) : $-2.29 (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis EPS (Diluted)?

Trulieve Cannabis's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.17. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.29.

Trulieve Cannabis's EPS (Basic) for the three months ended in Mar. 2024 was $-0.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.29.

Trulieve Cannabis's EPS without NRI for the three months ended in Mar. 2024 was $-0.16. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Trulieve Cannabis's highest 3-Year average EPS without NRI Growth Rate was 27.00% per year. The lowest was 27.00% per year. And the median was 27.00% per year.


Trulieve Cannabis EPS (Diluted) Historical Data

The historical data trend for Trulieve Cannabis's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis EPS (Diluted) Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.53 0.12 -1.31 -2.79

Trulieve Cannabis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -1.80 -0.14 -0.18 -0.17

Competitive Comparison of Trulieve Cannabis's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's PE Ratio distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's PE Ratio falls into.



Trulieve Cannabis EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Trulieve Cannabis's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-526.796-0)/188.974
=-2.79

Trulieve Cannabis's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-23.079-0)/189.493
=-0.12

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trulieve Cannabis  (OTCPK:TCNNF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Trulieve Cannabis EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis (Trulieve Cannabis) Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
Executives
Timothy E Mullany officer: Chief Financial Officer 3551 PLANO PARKWAY, THE COLONY TX 75056
Ryan Blust officer: Chief Financial Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Joy Malivuk officer: Chief Accounting Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Peter Healy director C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Rebecca L. Young officer: Chief Accounting Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kim A. Rivers director, 10 percent owner, officer: Chief Executive Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Thomas L Millner director, 10 percent owner
Thad Beshears director, 10 percent owner C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kyle Landrum officer: Chief Production Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Timothy Morey officer: Chief Sales Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Eric Powers officer: GC and Corporate Secretary C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Susan Thronson director C/O ANGIE'S LIST, INC., 1030 E. WASHINGTON STREET, INDIANPOLIS IN 46202
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Giannella Alvarez director C/O DOMTAR CORPORATION, 234 KINGSLEY PARK DRIVE, FORT MILL SC 29715
Jane C Morreau director